Kimia Farma Tbk PT
IDX:KAEF

Watchlist Manager
Kimia Farma Tbk PT Logo
Kimia Farma Tbk PT
IDX:KAEF
Watchlist
Price: 600 IDR Market Closed
Market Cap: 3.3T IDR
Have any thoughts about
Kimia Farma Tbk PT?
Write Note

Kimia Farma Tbk PT
Minority Interest

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Kimia Farma Tbk PT
Minority Interest Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Minority Interest CAGR 3Y CAGR 5Y CAGR 10Y
Kimia Farma Tbk PT
IDX:KAEF
Minority Interest
Rp377.7B
CAGR 3-Years
57%
CAGR 5-Years
-7%
CAGR 10-Years
37%
T
Tempo Scan Pacific Tbk PT
IDX:TSPC
Minority Interest
Rp496.4B
CAGR 3-Years
12%
CAGR 5-Years
9%
CAGR 10-Years
27%
Kalbe Farma Tbk PT
IDX:KLBF
Minority Interest
Rp1.7T
CAGR 3-Years
7%
CAGR 5-Years
16%
CAGR 10-Years
15%
Darya-Varia Laboratoria Tbk PT
IDX:DVLA
Minority Interest
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Soho Global Health Tbk PT
IDX:SOHO
Minority Interest
Rp0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Pyridam Farma Tbk PT
IDX:PYFA
Minority Interest
Rp194m
CAGR 3-Years
634%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Kimia Farma Tbk PT
Glance View

Market Cap
3.3T IDR
Industry
Pharmaceuticals

PT Kimia Farma Tbk engages in the production and distribution of healthcare products. The company is headquartered in Jakarta, Dki Jakarta and currently employs 11,668 full-time employees. The company went IPO on 2001-07-04. The firm produces medical devices and chemical materials. The firm is also involved in producing vegetable oil, iodine, and salts. Its products include Glucokaf, Diazink, Oracef, Kifarox, Magacid Suspension, Magaside Chewable Tablets, Nitrocafe Retarded, Nitrocafe Retard Forte, Trinolon, Raistine, VAGIZOL, Neviral, Hiviral Tablet, Duviral, Codipront Cum Expectorant, RETHAPHYL SR, and SUPRAFLU. Its generic products include PETHIDIN Hcl, PARACETAMOL, Diclofenac Sodium, MEPHANAMIC ACID, ANTALGIN, ANTASIDE DOEN, PYRANTEL, ALBENDAZOLE, METRONIDAZOLE TABLET, NEO BLOOD ADDING TABLET, FERROUS SULOATE SYRUP, DIMENHYDRINATE, ACYCLOVIR, AMBROXOL HCL, CHLOROQUINE, CHLORPROMAZINE HCL, CODEIN, CLOPIDOGREL, ERGOTAMINE COFFEE, METHYLERGOMETRINE TABLET SALUTE, MELOXICAM, and Pherphenazine.

KAEF Intrinsic Value
1 038.26 IDR
Undervaluation 42%
Intrinsic Value
Price

See Also

What is Kimia Farma Tbk PT's Minority Interest?
Minority Interest
377.7B IDR

Based on the financial report for Sep 30, 2024, Kimia Farma Tbk PT's Minority Interest amounts to 377.7B IDR.

What is Kimia Farma Tbk PT's Minority Interest growth rate?
Minority Interest CAGR 10Y
37%

Over the last year, the Minority Interest growth was -73%. The average annual Minority Interest growth rates for Kimia Farma Tbk PT have been 57% over the past three years , -7% over the past five years , and 37% over the past ten years .

Back to Top